Literature DB >> 8773610

Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease.

K Okuizumi1, O Onodera, K Seki, H Tanaka, Y Namba, K Ikeda, A M Saunders, M A Pericak-Vance, A D Roses, S Tsuji.   

Abstract

To determine whether the association of the very low density lipoprotein receptor (VLDL-R) gene with Alzheimer's disease (AD), which has recently been identified in Japanese AD patients, is commonly observed in AD patients of other ethnic backgrounds, we have investigated the allele frequency of the polymorphic CGG repeat in the 5'-UTR of the VLDL-R gene using a data set of 84 Caucasian AD patients with 104 Caucasian controls. Although the allele frequency of the 8-repeat allele was slightly lower, and that of 9-repeat allele was slightly higher, in the Caucasian AD patients than in Caucasian controls, the differences were not statistically significant. Multiple logistic regression analysis using apolipoprotein E4 (APOE4) allele, 5, 8-, or 9-repeat allele of the VLDL-R gene, sex, and age at onset as the predictors revealed that only the APOE4 allele was significantly associated with AD in the data set of the Caucasian AD patients and controls.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773610     DOI: 10.1002/ana.410400220

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 2.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

3.  System biology and bioinformatics pipeline to identify comorbidities risk association: Neurodegenerative disorder case study.

Authors:  Utpala Nanda Chowdhury; Shamim Ahmad; M Babul Islam; Salem A Alyami; Julian M W Quinn; Valsamma Eapen; Mohammad Ali Moni
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.